Testolone, also known as RAD-140, is a selective androgen receptor modulator (SARM) that has garnered significant attention in the fields of sports medicine and bodybuilding. Unlike traditional anabolic steroids, SARMs like Testolone are designed to selectively target androgen receptors in muscle and bone tissues, potentially offering the benefits of anabolic steroids without the associated side effects.
 
Testolone works by selectively binding to androgen receptors in muscle and bone tissues. This selective binding triggers anabolic activity, leading to increased muscle mass and strength. Unlike traditional anabolic steroids, Testolone does not convert to estrogen, thereby reducing the risk of estrogen-related side effects such as gynecomastia.
 
Testolone, scientifically known as RAD 140, Vosilasarm, or EP0062, is a selective androgen receptor modulator (SARM) recognized for its potent anabolic properties. This non-steroidal compound selectively targets androgen receptors in muscle and bone tissues, making it a valuable subject in research focused on muscle growth and bone density enhancement.

In laboratory studies, Testolone has demonstrated a strong affinity for androgen receptors, promoting the accrual of muscle mass and potentially aiding in the reduction of adipose tissue. Its selective action minimizes unwanted interactions with other tissues, which is a significant advantage over traditional anabolic agents. Researchers are particularly interested in its potential applications for understanding muscle-wasting conditions and age-related muscle loss.

Testolone's unique profile suggests potential in exploring hormonal pathways without the typical side effects associated with steroidal compounds. Its ability to stimulate anabolic activity while exhibiting minimal androgenic effects makes it an important compound in preclinical studies aiming to develop novel insights into muscle degeneration and osteoporosis.